Overview

Azithromycin Plus Chloroquine Versus Mefloquine for the Treatment of Uncomplicated Malaria in Africa

Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
The primary objective is to confirm the hypothesis that azithromycin plus chloroquine is non-inferior to mefloquine for the treatment of symptomatic, uncomplicated malaria due to P. falciparum.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Azithromycin
Chloroquine
Chloroquine diphosphate
Mefloquine